Children’s Hospital of Philadelphia researchers show that childhood-onset rheumatic and inflammatory diseases have unique genetic profiles, challenging the view they are simply earlier forms of adult illnesses. The findings could pave the way for more precise classifications and targeted treatments for young patients.
Researchers at Children’s Hospital of Philadelphia say childhood-onset rheumatic and inflammatory diseases have a genetic make-up that is not simply a younger version of adult illness, a finding that could help doctors classify these conditions more precisely and point towards new targeted treatments. The work, published in Annals of the Rheumatic Diseases, suggests that age and development may shape immune disease risk in ways that have been underappreciated in adult-centred research.
The team analysed 24 immune-mediated inflammatory diseases and compared genetic data from 18,086 patients with 131,019 controls. Their genome-wide association study found that inherited risk explained a substantial share of disease variation, ranging from 28.9% in allergic conditions to 61.9% in autoimmune disorders. The analysis identified 39 genome-wide significant variants, including 15 not previously reported, and 18 of those variants were shared across different disease categories.
According to the study authors, the results support a broader picture in which paediatric immune disease shares core pathways with adult illness but also reflects biological programmes that are especially active during growth and development. Hakon Hakonarson, senior author and director of CHOP’s Center for Applied Genomics, said the findings challenge the idea that childhood disorders are merely early forms of adult disease and highlight the need to study how genetics interacts with developmental context. CHOP’s long-running genetic studies of complex paediatric disorders and immune dysregulation have been designed to uncover exactly these kinds of disease mechanisms.
The findings also build on earlier work showing genetic overlap across several paediatric autoimmune diseases, while extending that approach to a wider set of immune-mediated conditions including inflammatory bowel disease and food allergy research programmes at CHOP. Researchers say pooling multiple diseases together can reveal shared biology that single-disease studies miss, offering a framework for earlier risk assessment, better disease subtyping and eventually more precise therapies for children.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
